BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15998594)

  • 1. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
    Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
    Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
    Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
    Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
    Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
    J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytics in the treatment of parapneumonic effusions.
    Bouros D; Schiza S; Siafakas N
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; Ozyürek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
    Barthwal MS
    Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural fibrinolytic therapy for pleural infection.
    Bouros D; Tzouvelekis A; Antoniou KM; Heffner JE
    Pulm Pharmacol Ther; 2007; 20(6):616-26. PubMed ID: 17049447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
    Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
    Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
    Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
    Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.
    Laisaar T; Püttsepp E; Laisaar V
    Thorac Cardiovasc Surg; 1996 Oct; 44(5):252-6. PubMed ID: 8948554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R
    Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
    Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
    Porcel JM
    Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.